Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
David Milch, Chairman of the Board of Directors. Dr. David Milch has served as our Chairman of the Board of Directors, began his career in medical research and thereafter began investing in venture opportunities in technology and life sciences. Dr. Milch has invested in a wide variety of opportunities including Heart Guard (start -up ), The American Blood Institute (private sale), Intelligent Medical Imaging (IPO), Biofield (IPO), Nitinol (IPO), Datatec Systems (reverse merger), Warp Technologies (reverse merger), MiniMed (acquired by Medtronic), Advanced Bionics (acquired by Boston Scientific), Theravance (IPO), Contrafect (IPO), Alpha Tau (private equity), Cyteir Therapeutics (private equity), Serpin Pharma (private equity), Wisdo (private equity) and Games 24x7 (private equity). Dr. Milch is the Founder and Chairman of AllMeD Solutions Ltd, a public medical device technology company based in Israel. Dr.
This record is keyed to SEC CIK 0001233803 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 46 institutional-holder rows on these vehicles, under 24 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.